Megace and Hyperthyroidism - a phase IV clinical study of FDA data

Summary:

Hyperthyroidism is reported as a side effect among people who take Megace (megestrol acetate), especially for people who are male, 40-49 old, have been taking the drug for 1 - 6 months also take Ativan, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Hyperthyroidism when taking Megace. It is created by eHealthMe based on reports of 9,969 people who have side effects when taking Megace from the FDA, and is updated regularly.

What is Megace?

Megace has active ingredients of megestrol acetate. It is often used in weight loss. eHealthMe is studying from 10,095 Megace users. Check the latest studies of Megace.

What is Hyperthyroidism?

Hyperthyroidism (over activity of the thyroid gland) is found to be associated with 1,008 drugs and 1,435 conditions by eHealthMe. Check the latest studies of Hyperthyroidism.

On Apr, 24, 2026

9,969 people reported to have side effects when taking Megace.
Among them, 26 people (0.26%) have Hyperthyroidism.

Among these 26 people:

How long have people been on Megace when they have Hyperthyroidism? *

What is the gender of people who have Hyperthyroidism when taking Megace? *

female: 11.54 %
male: 88.46 %

What is the age of people who have Hyperthyroidism when taking Megace? *

What are other drugs people take besides Megace? *

What are other side effects people have besides Hyperthyroidism? *

Pneumonia: 18 people, 69.23%
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 17 people, 65.38%
Cellulitis (infection under the skin): 17 people, 65.38%
Pleural Effusion (water on the lungs): 17 people, 65.38%
Anaemia (lack of blood): 17 people, 65.38%
Urinary Tract Infection: 16 people, 61.54%
Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 16 people, 61.54%
Immunodeficiency Disorders: 15 people, 57.69%
Febrile Neutropenia (fever with reduced white blood cells): 15 people, 57.69%
Impaired Gastric Emptying: 15 people, 57.69%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 15 people, 57.69%
Post Procedural Hypothyroidism: 3 people, 11.54%
Arrhythmias (irregular heartbeat): 3 people, 11.54%
Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 3 people, 11.54%
Renal Cell Carcinoma (a kidney cancer): 2 people, 7.69%
Oedema (fluid collection in tissue): 2 people, 7.69%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 2 people, 7.69%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 7.69%
Hyperglycemia (high blood sugar): 2 people, 7.69%
High Blood Pressure: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Megace and have Hyperthyroidism?

- Check whether Hyperthyroidism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Megace:

Megace (10,095 reports)

Hyperthyroidism treatments and more:

Hyperthyroidism (26,831 reports)

Browse all side effects of Megace:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperthyroidism:

Hyperthyroidism (1,008 drugs)

Browse all the conditions that are associated with Hyperthyroidism:

Hyperthyroidism (1,435 conditions)

Related publications that referenced our studies

Dulani S, Dulani R, Lele S, Diagavane S, Anjankar S, Jaiswal N, Subramaniam PS, Juneja R, "Chronic Subdural Haematoma in a Case of Hyperthyroidism Presenting with Papilledema", Chinese Medicine, 2012 Dec .
Dulani S, Dulani R, Lele S, Diagavane S, Anjankar S, Jaiswal N, Subramaniam PS, Juneja R, "Chronic Subdural Haematoma in a Case of Hyperthyroidism Presenting with Papilledema", Chinese Medicine, 2012 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on megestrol acetate (the active ingredients of Megace) and Megace (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.